✦ LIBER ✦

A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma

✍ Scribed by Brian M. J. Cantwell; C. R. Franks; Adrian L. Harris

Publisher: Springer
Year: 1986
Tongue: English
Weight: 257 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00273405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of pirarubicin in malig

A phase II study of pirarubicin in malignant pleural mesothelioma

✍ E. Kaukel; G. Koschel; U. Gatzemeyer; E. Salewski 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 3 views

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.

Menogaril in the treatment of malignant

Menogaril in the treatment of malignant mesothelioma: A phase II study

✍ C. A. Hudis; D. P. Kelsen 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 275 KB

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Philippe Astoul; Diane Picat-Joossen; Jean-Regis Viallat; Christian Boutin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## Background: The prognosis associated with malignant pleural mesothelioma (mpm) is poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. therefore, new therapeutic strategies, including intrapleural immunotherapy, are being investigated. several clinical studies have demo

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Theodore G. Karrison; Nicholas J. Vogelzang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean that the three-grading system is worthless; the authors simply showed tha